Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

Name: Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
License: Public Domain

Children's Oncology Group

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

b acute lymphoblastic leukemia, b lymphoblastic lymphoma, central nervous system leukemia, mixed phenotype acute leukemia, testicular leukemia

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 628551
Conceptio Open Knowledge Archive — every document is proof-bundled with source, license, and retrieval metadata.